Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114.
Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
AJR Am J Roentgenol. 2022 Jul;219(1):15-23. doi: 10.2214/AJR.21.26717. Epub 2021 Oct 6.
Hundreds of imaging-based artificial intelligence (AI) models have been developed in response to the COVID-19 pandemic. AI systems that incorporate imaging have shown promise in primary detection, severity grading, and prognostication of outcomes in COVID-19, and have enabled integration of imaging with a broad range of additional clinical and epidemiologic data. However, systematic reviews of AI models applied to COVID-19 medical imaging have highlighted problems in the field, including methodologic issues and problems in real-world deployment. Clinical use of such models should be informed by both the promise and potential pitfalls of implementation. How does a practicing radiologist make sense of this complex topic, and what factors should be considered in the implementation of AI tools for imaging of COVID-19? This critical review aims to help the radiologist understand the nuances that impact the clinical deployment of AI for imaging of COVID-19. We review imaging use cases for AI models in COVID-19 (e.g., diagnosis, severity assessment, and prognostication) and explore considerations for AI model development and testing, deployment infrastructure, clinical user interfaces, quality control, and institutional review board and regulatory approvals, with a practical focus on what a radiologist should consider when implementing an AI tool for COVID-19.
针对 COVID-19 疫情,已经开发了数百种基于成像的人工智能 (AI) 模型。在 COVID-19 的初步检测、严重程度分级和预后评估中,结合成像的 AI 系统显示出了前景,并且还实现了将成像与广泛的其他临床和流行病学数据相结合。然而,对应用于 COVID-19 医学成像的 AI 模型的系统评价突出了该领域存在的问题,包括方法学问题和实际部署中的问题。此类模型的临床应用应同时考虑到实施的前景和潜在陷阱。那么,实践中的放射科医生如何理解这个复杂的课题,以及在 COVID-19 成像中实施 AI 工具时应该考虑哪些因素?本批判性综述旨在帮助放射科医生了解影响 COVID-19 成像中 AI 临床部署的细微差别。我们回顾了 COVID-19 中 AI 模型的成像应用案例(例如,诊断、严重程度评估和预后),并探讨了 AI 模型开发和测试、部署基础设施、临床用户界面、质量控制以及机构审查委员会和监管机构批准的注意事项,重点关注放射科医生在实施 COVID-19 的 AI 工具时应考虑的因素。